Selected research
Industry Research
Pharma Continuous Granulation Industry Research Report 2026
Market perspective
The global Pharma Continuous Granulation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Pharma Continuous Granulation is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Pharma Continuous Granulation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Pharma Continuous Granulation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Pharma Continuous Granulation include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Pharma Continuous Granulation market in revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Pharma Continuous Granulation.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Pharma Continuous Granulation Market by Company
LB Bohle
GEA
LCI
Chansemt
Thermo Fisher Scientific
Syntegon
Senieer
LÖDIGE
Glatt
Gericke
Pharma Continuous Granulation Segment by Type
Dry Method
Wet Method
Pharma Continuous Granulation Segment by Application
Tablets
Capsules
Others
Pharma Continuous Granulation Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharma Continuous Granulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pharma Continuous Granulation and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharma Continuous Granulation.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Pharma Continuous Granulation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Pharma Continuous Granulation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Pharma Continuous Granulation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dry Method
- Wet Method
Applications
- Tablets
- Capsules
- Others
Companies covered
- LB Bohle
- GEA
- LCI
- Chansemt
- Thermo Fisher Scientific
- Syntegon
- Senieer
- LÖDIGE
- Glatt
- Gericke
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Pharma Continuous Granulation by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Dry Method
- 2.2.3 Wet Method
- 2.3 Pharma Continuous Granulation by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tablets
- 2.3.3 Capsules
- 2.3.4 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Pharma Continuous Granulation Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Pharma Continuous Granulation Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Pharma Continuous Granulation Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Pharma Continuous Granulation Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Pharma Continuous Granulation Production by Manufacturers (2021-2026)
- 3.2 Global Pharma Continuous Granulation Production Value by Manufacturers (2021-2026)
- 3.3 Global Pharma Continuous Granulation Average Price by Manufacturers (2021-2026)
- 3.4 Global Pharma Continuous Granulation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pharma Continuous Granulation Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Pharma Continuous Granulation Manufacturers, Product Type & Application
- 3.7 Global Pharma Continuous Granulation Manufacturers Established Date
- 3.8 Global Pharma Continuous Granulation Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 LB Bohle
- 4.1.1 LB Bohle Pharma Continuous Granulation Company Information
- 4.1.2 LB Bohle Pharma Continuous Granulation Business Overview
- 4.1.3 LB Bohle Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
- 4.1.4 LB Bohle Product Portfolio
- 4.1.5 LB Bohle Recent Developments
- 4.2 GEA
- 4.2.1 GEA Pharma Continuous Granulation Company Information
- 4.2.2 GEA Pharma Continuous Granulation Business Overview
- 4.2.3 GEA Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
- 4.2.4 GEA Product Portfolio
- 4.2.5 GEA Recent Developments
- 4.3 LCI
- 4.3.1 LCI Pharma Continuous Granulation Company Information
- 4.3.2 LCI Pharma Continuous Granulation Business Overview
- 4.3.3 LCI Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
- 4.3.4 LCI Product Portfolio
- 4.3.5 LCI Recent Developments
- 4.4 Chansemt
- 4.4.1 Chansemt Pharma Continuous Granulation Company Information
- 4.4.2 Chansemt Pharma Continuous Granulation Business Overview
- 4.4.3 Chansemt Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
- 4.4.4 Chansemt Product Portfolio
- 4.4.5 Chansemt Recent Developments
- 4.5 Thermo Fisher Scientific
- 4.5.1 Thermo Fisher Scientific Pharma Continuous Granulation Company Information
- 4.5.2 Thermo Fisher Scientific Pharma Continuous Granulation Business Overview
- 4.5.3 Thermo Fisher Scientific Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
- 4.5.4 Thermo Fisher Scientific Product Portfolio
- 4.5.5 Thermo Fisher Scientific Recent Developments
- 4.6 Syntegon
- 4.6.1 Syntegon Pharma Continuous Granulation Company Information
- 4.6.2 Syntegon Pharma Continuous Granulation Business Overview
- 4.6.3 Syntegon Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
- 4.6.4 Syntegon Product Portfolio
- 4.6.5 Syntegon Recent Developments
- 4.7 Senieer
- 4.7.1 Senieer Pharma Continuous Granulation Company Information
- 4.7.2 Senieer Pharma Continuous Granulation Business Overview
- 4.7.3 Senieer Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
- 4.7.4 Senieer Product Portfolio
- 4.7.5 Senieer Recent Developments
- 4.8 LÖDIGE
- 4.8.1 LÖDIGE Pharma Continuous Granulation Company Information
- 4.8.2 LÖDIGE Pharma Continuous Granulation Business Overview
- 4.8.3 LÖDIGE Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
- 4.8.4 LÖDIGE Product Portfolio
- 4.8.5 LÖDIGE Recent Developments
- 4.9 Glatt
- 4.9.1 Glatt Pharma Continuous Granulation Company Information
- 4.9.2 Glatt Pharma Continuous Granulation Business Overview
- 4.9.3 Glatt Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
- 4.9.4 Glatt Product Portfolio
- 4.9.5 Glatt Recent Developments
- 4.10 Gericke
- 4.10.1 Gericke Pharma Continuous Granulation Company Information
- 4.10.2 Gericke Pharma Continuous Granulation Business Overview
- 4.10.3 Gericke Pharma Continuous Granulation Production, Value and Gross Margin (2021-2026)
- 4.10.4 Gericke Product Portfolio
- 4.10.5 Gericke Recent Developments
5 Global Pharma Continuous Granulation Production by Region
- 5.1 Global Pharma Continuous Granulation Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Pharma Continuous Granulation Production by Region: 2021-2032
- 5.2.1 Global Pharma Continuous Granulation Production by Region: 2021-2026
- 5.2.2 Global Pharma Continuous Granulation Production Forecast by Region (2027-2032)
- 5.3 Global Pharma Continuous Granulation Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Pharma Continuous Granulation Production Value by Region: 2021-2032
- 5.4.1 Global Pharma Continuous Granulation Production Value by Region: 2021-2026
- 5.4.2 Global Pharma Continuous Granulation Production Value Forecast by Region (2027-2032)
- 5.5 Global Pharma Continuous Granulation Market Price Analysis by Region (2021-2026)
- 5.6 Global Pharma Continuous Granulation Production and Value, YOY Growth
- 5.6.1 North America Pharma Continuous Granulation Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Pharma Continuous Granulation Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Pharma Continuous Granulation Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Pharma Continuous Granulation Production Value Estimates and Forecasts (2021-2032)
6 Global Pharma Continuous Granulation Consumption by Region
- 6.1 Global Pharma Continuous Granulation Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pharma Continuous Granulation Consumption by Region (2021-2032)
- 6.2.1 Global Pharma Continuous Granulation Consumption by Region: 2021-2026
- 6.2.2 Global Pharma Continuous Granulation Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pharma Continuous Granulation Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pharma Continuous Granulation Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pharma Continuous Granulation Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Pharma Continuous Granulation Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Pharma Continuous Granulation Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Pharma Continuous Granulation Production by Type (2021-2032)
- 7.1.1 Global Pharma Continuous Granulation Production by Type (2021-2032) & (K Units)
- 7.1.2 Global Pharma Continuous Granulation Production Market Share by Type (2021-2032)
- 7.2 Global Pharma Continuous Granulation Production Value by Type (2021-2032)
- 7.2.1 Global Pharma Continuous Granulation Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Pharma Continuous Granulation Production Value Market Share by Type (2021-2032)
- 7.3 Global Pharma Continuous Granulation Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Pharma Continuous Granulation Production by Application (2021-2032)
- 8.1.1 Global Pharma Continuous Granulation Production by Application (2021-2032) & (K Units)
- 8.1.2 Global Pharma Continuous Granulation Production Market Share by Application (2021-2032)
- 8.2 Global Pharma Continuous Granulation Production Value by Application (2021-2032)
- 8.2.1 Global Pharma Continuous Granulation Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Pharma Continuous Granulation Production Value Market Share by Application (2021-2032)
- 8.3 Global Pharma Continuous Granulation Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Pharma Continuous Granulation Value Chain Analysis
- 9.1.1 Pharma Continuous Granulation Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Pharma Continuous Granulation Production Mode & Process
- 9.2 Pharma Continuous Granulation Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pharma Continuous Granulation Distributors
- 9.2.3 Pharma Continuous Granulation Customers
10 Global Pharma Continuous Granulation Analyzing Market Dynamics
- 10.1 Pharma Continuous Granulation Industry Trends
- 10.2 Pharma Continuous Granulation Industry Drivers
- 10.3 Pharma Continuous Granulation Industry Opportunities and Challenges
- 10.4 Pharma Continuous Granulation Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst